APPLY FOR 2023 – 2024


SBV in the Press: Puducherry institution chosen for human clinical trials of Covaxin

MGMCRI is selected as one of the few notable centers in our country for conducting Phase III Multi-centric Clinical Trial of COVAXIN. This remarkable achievement got a special mention in newspapers. At MGMCRI, the trials will begin soon; 1,200 volunteers likely to be covered. To know further please click on the link given below and also check the attachment for details.